SQM: Royalty Overpayments May Have Distorted Q2 EBITDA
Overpayment of royalties distorted EBITDA and net income. Volume growth is accelerating to 37% in 2H22. Click here to read my analysis of the stock.
SQM: Royalty Overpayments May Have Distorted Q2 EBITDA
Overpayment of royalties distorted EBITDA and net income. Volume growth is accelerating to 37% in 2H22. Click here to read my analysis of the stock.